Drug
Asoprisnil clinical trials
Also written J867.
- studies test it
- 15
- open now
- 0
- in phase 3
- 6
- first study started
- 2000
How studies write it
Studies that test it under each name
Studies by the year they started
15 studies that test it; most in 2002 (4)
| Year | Studies |
|---|---|
| 2000 | 3 |
| 2001 | 3 |
| 2002 | 4 |
| 2003 | 3 |
| 2004 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 9
- Phase 3
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 15 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses asoprisnil is read from its arms, and is right about nine times in ten.
Testing it · 15
- Menorrhagia Study in Women With Treatment-resistant MenorrhagiaCompletedPhase 2BayerNCT00288691Written as Asoprisnil (BAY86-5294)
- A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.CompletedPhase 2AbbottNCT00156182Written as Asoprisnil
- A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Women With Endometriosis From Study M01-398CompletedPhase 2AbbottNCT00160420Written as Asoprisnil
- A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal WomenCompletedPhase 2AbbottNCT00152282Written as Asoprisnil/Premarin
- Treatment of Uterine Fibroids With Asoprisnil(J867)CompletedPhase 3AbbottNCT00152269Written as Asoprisnil
- A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a HysterectomyCompletedPhase 2AbbottNCT00150644Written as Asoprisnil
- A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine FibroidsCompletedPhase 3AbbottNCT00160381Written as Asoprisnil
- Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine FibroidsCompletedPhase 3AbbottNCT00156195Written as Asoprisnil
- A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administration to Postmenopausal WomenCompletedPhase 2AbbottNCT00152295Written as Asoprisnil/Premarin
- A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in the Treatment of Women With EndometriosisCompletedPhase 2AbbottNCT00160446Written as Asoprisnil
- Safety of Treatment of Uterine Fibroids With AsoprisnilCompletedPhase 3AbbottNCT00156208Written as Asoprisnil
- A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine FibroidsCompletedPhase 2AbbottNCT00160459Written as Asoprisnil
- A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine FibroidsCompletedPhase 3AbbottNCT00152256Written as Asoprisnil
- A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Women With Endometriosis.CompletedPhase 2AbbottNCT00160433Written as Asoprisnil
- Study of Asoprisnil in the Treatment of Uterine Fibroids.CompletedPhase 3AbbottNCT00156156Written as Asoprisnil
Codes
What other systems call asoprisnil · ClinicalTrials.gg INT004681
- MeSH (NLM) C488516asoprisnilOne source NLM
- UNII (FDA) 72W09924WPASOPRISNILConfirmed FDA, NLM, Wikidata
- Wikidata Q4807593asoprisnilConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C91054AsoprisnilOne source FDA
- DrugBank DB06680One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C488516 | asoprisnil | One source NLM |
| UNII (FDA) | 72W09924WP | ASOPRISNIL | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q4807593 | asoprisnil | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C91054 | Asoprisnil | One source FDA |
| DrugBank | DB06680 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.